Wadman RI et al. |
Drug treatment for spinal muscular atrophy types II and III. |
2012 |
Cochrane Database Syst Rev |
pmid:22513940
|
Balschi JA |
In vivo clinical measures of intermediary metabolism are inadequate: can a new magnetic resonance spectroscopy technology do better? |
2012 |
Circ Cardiovasc Imaging |
pmid:22438422
|
Schroeder MA et al. |
The cycling of acetyl-coenzyme A through acetylcarnitine buffers cardiac substrate supply: a hyperpolarized 13C magnetic resonance study. |
2012 |
Circ Cardiovasc Imaging |
pmid:22238215
|
Morand R et al. |
Effect of short- and long-term treatment with valproate on carnitine homeostasis in humans. |
2012 |
Ther Drug Monit |
pmid:22743351
|
Patel SP et al. |
Acetyl-L-carnitine treatment following spinal cord injury improves mitochondrial function correlated with remarkable tissue sparing and functional recovery. |
2012 |
Neuroscience |
pmid:22445934
|
Zhang R et al. |
Neuroprotective effects of pre-treatment with l-carnitine and acetyl-L-carnitine on ischemic injury in vivo and in vitro. |
2012 |
Int J Mol Sci |
pmid:22408439
|
Hu C et al. |
Inhibition of OCTN2-mediated transport of carnitine by etoposide. |
2012 |
Mol. Cancer Ther. |
pmid:22389472
|
Wu R et al. |
Metabolomic analysis reveals that carnitines are key regulatory metabolites in phase transition of the locusts. |
2012 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:22328148
|
Boss A et al. |
Skeletal muscle ¹H MRSI before and after prolonged exercise. II. visibility of free carnitine. |
2012 |
Magn Reson Med |
pmid:22287218
|
Smeland OB et al. |
Dietary supplementation with acetyl-l-carnitine in seizure treatment of pentylenetetrazole kindled mice. |
2012 |
Neurochem. Int. |
pmid:22709675
|